DA Davidson Upgrades Oracle to Buy, $180 Price Target
DA Davidson upgrades Oracle to Buy, citing strong OpenAI outlook and reduced risks, with a $180 price target.
Already have an account? Sign in.
DA Davidson upgrades Oracle to Buy, citing strong OpenAI outlook and reduced risks, with a $180 price target.
ADC Therapeutics fell by nearly half after ZYNLONTA showed better cancer control but higher rates of serious side effects and deaths.
Despite beating Q1 estimates and raising full-year guidance, CrowdStrike shares plunged after hours as operating expenses surged 15% on heavy AI investments.
Broadcom reported $22.2B revenue and 143% AI growth in Q2 2026, but shares dropped after Q3 guidance fell short of Wall Street’s blowout expectations.